# TRIM6

## Overview
TRIM6 is a gene that encodes the protein tripartite motif containing 6, which is a member of the tripartite motif (TRIM) family of proteins. This family is characterized by a conserved tripartite motif that includes a RING domain, B-box domains, and a coiled-coil region, classifying TRIM6 as an E3 ubiquitin ligase. The TRIM6 protein plays a significant role in the regulation of immune responses, particularly in antiviral defense, by facilitating the synthesis of unanchored K48-linked polyubiquitin chains essential for activating the IKKε kinase. This activation is crucial for the phosphorylation of STAT1, a key step in the type I interferon signaling pathway, which is vital for the induction of interferon-stimulated genes that restrict viral replication (van2020VAMP8; Bharaj2016The). Additionally, TRIM6 is involved in various cellular processes, including protein stability and cellular homeostasis, and has been implicated in the progression of colorectal cancer through its interactions with other proteins, influencing cell proliferation, migration, and metastasis (Zheng2020TRIM6; Zhao2021Tripartite).

## Structure
TRIM6 is a member of the TRIM protein family, characterized by a conserved tripartite motif that includes a RING domain, one or two B-box domains, and a coiled-coil region. This motif is crucial for its function as an E3 ubiquitin ligase, facilitating post-translational modifications such as ubiquitination (Sardiello2008Genomic; Koepke2021The). The RING domain is a zinc-binding domain that interacts with ubiquitin-conjugating enzymes, while the B-box domains are critical for the structural integrity and function of TRIM proteins (Sardiello2008Genomic).

TRIM6 also contains a C-terminal SPRY domain, which is involved in protein-protein interactions and is essential for its role in antiviral immunity. This domain allows TRIM6 to interact with other proteins, such as IKKε, to regulate signaling pathways like the JAK-STAT pathway (Hatakeyama2017TRIM). The SPRY domain is also implicated in the formation of ubiquitin-rich bodies in the cytoplasm, which are important for antiviral responses (Bharaj2016The).

TRIM6 can form homodimers or heterodimers, which may enhance its substrate recognition and enzymatic regulation (Hatakeyama2017TRIM). The protein is conserved across mammalian species, indicating its evolutionary importance (Bharaj2016The).

## Function
TRIM6 is a member of the tripartite motif (TRIM) family of proteins, which are characterized by a RING finger, B-box, and coiled-coil domain. In healthy human cells, TRIM6 functions as an E3 ubiquitin ligase, playing a crucial role in the regulation of immune responses, particularly in antiviral defense. It is involved in the synthesis of unanchored K48-linked polyubiquitin chains, which are essential for the activation of the IKKε kinase. This activation leads to the phosphorylation of STAT1, a key step in the type I interferon (IFN-I) signaling pathway, which is vital for the induction of interferon-stimulated genes (ISGs) that restrict viral replication (Bharaj2016The; van2020VAMP8).

TRIM6 is active in both the cytoplasm and nucleus, where it influences protein stability and cellular homeostasis. It facilitates the oligomerization and autophosphorylation of IKKε, promoting downstream signaling necessary for an effective antiviral response (Hatakeyama2017TRIM; Versteeg2014InTRIMsic). The protein's activity is crucial for maintaining the body's defense against viral infections, as evidenced by increased viral replication in cells lacking TRIM6 (van2020VAMP8).

## Clinical Significance
TRIM6 has been implicated in the progression of colorectal cancer (CRC) through its role in cell proliferation, migration, and metastasis. Overexpression of TRIM6 in CRC cells enhances cell migration and invasion by modulating the SOCS2-STAT3 signaling pathway. This overexpression leads to decreased SOCS2 expression and increased STAT3 activation, promoting epithelial-mesenchymal transition (EMT) markers such as Snail1, Twist1, and MMP2, which are associated with tumor cell migration and invasion (Zhao2021Tripartite). TRIM6 expression is also correlated with larger tumor size, advanced clinical stage, and poor disease-free survival, suggesting its potential as a prognostic marker for CRC recurrence (Zheng2020TRIM6; Zhao2021Tripartite).

In addition to its role in CRC, TRIM6 is involved in the regulation of cell proliferation through its interaction with TIS21, an anti-proliferative protein. TRIM6 promotes the ubiquitination and degradation of TIS21, affecting the levels of FoxM1, Cyclin B1, and c-Myc, which are crucial for cell cycle progression. This interaction highlights TRIM6's potential as a therapeutic target, particularly in enhancing the sensitivity of CRC cells to chemotherapeutic agents like thiostrepton (Zheng2020TRIM6).

## Interactions
TRIM6 is known to interact with several proteins, playing a significant role in various cellular processes. One of its key interactions is with the matrix protein of the Nipah virus (NiV-M), where TRIM6 is targeted for degradation. This interaction inhibits the synthesis of unanchored K48-linked polyubiquitin chains, crucial for activating the IKKε kinase, thereby impairing the type-I interferon (IFN) antiviral response (Bharaj2016The). The degradation of TRIM6 by NiV-M is a proteasome-independent process, as proteasome inhibition does not restore TRIM6 levels (Bharaj2016The).

TRIM6 also interacts with TSC1 and TSC2 proteins, influencing their ubiquitination and degradation, which affects the mTORC1 signaling pathway. This interaction is crucial for understanding the molecular mechanisms underlying renal fibrosis (Liu2021The).

In colorectal cancer cells, TRIM6 interacts with TIS21, promoting its ubiquitination and reducing its stability. This interaction is associated with increased cell proliferation and tumorigenesis (Zheng2020TRIM6). TRIM6 also interacts with SOCS2, affecting STAT3 activation and promoting cell migration and invasion in colorectal cancer (Zhao2021Tripartite).


## References


[1. (van2020VAMP8) Sarah van Tol, Colm Atkins, Preeti Bharaj, Kendra N. Johnson, Adam Hage, Alexander N. Freiberg, and Ricardo Rajsbaum. Vamp8 contributes to the trim6-mediated type i interferon antiviral response during west nile virus infection. Journal of Virology, January 2020. URL: http://dx.doi.org/10.1128/jvi.01454-19, doi:10.1128/jvi.01454-19. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.01454-19)

[2. (Zheng2020TRIM6) Shuier Zheng, Chenliang Zhou, Yonggang Wang, Hongtao Li, Yong Sun, and Zan Shen. Trim6 promotes colorectal cancer cells proliferation and response to thiostrepton by tis21/foxm1. Journal of Experimental &amp; Clinical Cancer Research, January 2020. URL: http://dx.doi.org/10.1186/s13046-019-1504-5, doi:10.1186/s13046-019-1504-5. This article has 26 citations.](https://doi.org/10.1186/s13046-019-1504-5)

[3. (Zhao2021Tripartite) Hongjian Zhao, Junjun Huang, Ming Chen, Baoru Li, Xinran Chen, and Mingqing Zhou. Tripartite motif protein 6 promotes colorectal cancer cell migration and metastasis via socs2-stat3 signaling. Frontiers in Oncology, September 2021. URL: http://dx.doi.org/10.3389/fonc.2021.695525, doi:10.3389/fonc.2021.695525. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.695525)

[4. (Sardiello2008Genomic) Marco Sardiello, Stefano Cairo, Bianca Fontanella, Andrea Ballabio, and Germana Meroni. Genomic analysis of the trim family reveals two groups of genes with distinct evolutionary properties. BMC Evolutionary Biology, August 2008. URL: http://dx.doi.org/10.1186/1471-2148-8-225, doi:10.1186/1471-2148-8-225. This article has 220 citations.](https://doi.org/10.1186/1471-2148-8-225)

[5. (Liu2021The) Weiwei Liu, Yang Yi, Chuanfu Zhang, Baojuan Zhou, Lin Liao, Wenrui Liu, Jing Hu, Qiming Xu, Jie Chen, and Jianrao Lu. The expression of trim6 activates the mtorc1 pathway by regulating the ubiquitination of tsc1-tsc2 to promote renal fibrosis. Frontiers in Cell and Developmental Biology, February 2021. URL: http://dx.doi.org/10.3389/fcell.2020.616747, doi:10.3389/fcell.2020.616747. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.616747)

[6. (Bharaj2016The) Preeti Bharaj, Yao E. Wang, Brian E. Dawes, Tatyana E. Yun, Arnold Park, Benjamin Yen, Christopher F. Basler, Alexander N. Freiberg, Benhur Lee, and Ricardo Rajsbaum. The matrix protein of nipah virus targets the e3-ubiquitin ligase trim6 to inhibit the ikkε kinase-mediated type-i ifn antiviral response. PLOS Pathogens, 12(9):e1005880, September 2016. URL: http://dx.doi.org/10.1371/journal.ppat.1005880, doi:10.1371/journal.ppat.1005880. This article has 86 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.ppat.1005880)

[7. (Hatakeyama2017TRIM) Shigetsugu Hatakeyama. Trim family proteins: roles in autophagy, immunity, and carcinogenesis. Trends in Biochemical Sciences, 42(4):297–311, April 2017. URL: http://dx.doi.org/10.1016/j.tibs.2017.01.002, doi:10.1016/j.tibs.2017.01.002. This article has 577 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tibs.2017.01.002)

[8. (Versteeg2014InTRIMsic) Gijs A. Versteeg, Stefan Benke, Adolfo García-Sastre, and Ricardo Rajsbaum. Intrimsic immunity: positive and negative regulation of immune signaling by tripartite motif proteins. Cytokine &amp; Growth Factor Reviews, 25(5):563–576, October 2014. URL: http://dx.doi.org/10.1016/j.cytogfr.2014.08.001, doi:10.1016/j.cytogfr.2014.08.001. This article has 106 citations.](https://doi.org/10.1016/j.cytogfr.2014.08.001)

[9. (Koepke2021The) Lennart Koepke, Michaela U Gack, and Konstantin MJ Sparrer. The antiviral activities of trim proteins. Current Opinion in Microbiology, 59:50–57, February 2021. URL: http://dx.doi.org/10.1016/j.mib.2020.07.005, doi:10.1016/j.mib.2020.07.005. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mib.2020.07.005)